
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation
Daniel P. Walker, F. Christopher Bi, Amit S. Kalgutkar, Jonathan N. Bauman, Sabrina X. Zhao, John R. Soglia, Gary E. Aspnes, Daniel W. Kung, Jacquelyn Klug-McLeod, Michael P. Zawistoski, Molly A. McGlVolume:
18
Année:
2008
Langue:
english
Pages:
7
DOI:
10.1016/j.bmcl.2008.10.030
Fichier:
PDF, 345 KB
english, 2008